Intracranial activity of first-line immune checkpoint inhibitors combined with chemotherapy in advanced non-small cell lung cancer

समान संसाधन

• Clinical outcomes for immune checkpoint inhibitors plus chemotherapy in non-small-cell lung cancer patients with uncommon driver gene alterations
  द्वारा: Haoyue Qin, और अन्य
  प्रकाशित: (2024-08-01)
• PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study
  द्वारा: Zhe Huang, और अन्य
  प्रकाशित: (2022-11-01)
• Potential utility of albumin–bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors
  द्वारा: Lianxi Song, और अन्य
  प्रकाशित: (2025-02-01)
• Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker study
  द्वारा: Yongchang Zhang, और अन्य
  प्रकाशित: (2022-09-01)
• Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patients
  द्वारा: Sarah Haebe, और अन्य
  प्रकाशित: (2025-01-01)